iRehab
IREHAB HAS OFFICIALLY HIT RECRUITMENT TARGET
Huge thank you to all sites and participants who have made this happen
Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge: a randomised controlled assessor-blind clinical and cost-effectiveness trial with internal pilot
People treated in intensive care need a great deal of special care and support. After discharge from hospital, some people find their muscles are still weak and their ability to exercise and to do everyday things may still be affected. They can also have confused memories of their time in the intensive care unit. For most people, these problems get better on their own, but for other people, they may continue for a long time after leaving hospital. iRehab will investigate the effects of:
-
- A six week multicomponent, rehabilitation intervention, delivered remotely by a core intervention team. In brief, the intervention includes four components: weekly symptom management; targeted exercise; psychological support and information/peer support.
- Compared to Standard Care, not involving structured rehabilitation.
Sample Size: 428 participants (control n=197; intervention n=231)
Primary outcome is health related quality of life at 8 weeks post randomisation. Secondary outcomes include health-related QoL (at six months), physical function, fatigue, anxiety and depression, healthcare resource use at eight weeks and six months post-randomisation
Trial Duration: 1st January 2022- 31st April 2025; Trial End Date: 31st January 2026
As of 15th April 2025
Latest News:
2025
15th April: iRehab has hit target!
31st March: Winner of Marchs prize draw.... The James Cook University Hospital
25th March: 19 participants to go
25th March: 20 participants to go
28th February: Winner of Februarys prize draw.... The Royal Glamorgan Hospital
31st January: Winner of Januarys prize draw.... Rotherham District General Hospital
9th January: Competition launched- Monthly Prize Draw, every site who registers a participant will be entered, more registrations the more entries
2024
September: Extension approved. Please continue to recruit as normal
4th July: We're waiting to hear the outcome of the extension application with the NIHR
30th April: 250 participants have been randomised to iRehab
5th March: Half way target of 214 reached
14th Febuary: 200 participants have been randomised to iRehab
8th January: 190 participants have been randomised to iRehab
2023
18th August: 110 participants have been randomised to iRehab
9th August: 35 sites open to recruitment
8th August: 100 participants have been randomised to iRehab
7th July: 90 participants have been randomised to iRehab
19th June: 80 participants have been randomised to iRehab
11th May: 60 participants randomised to iRehab
26th April: 50 participants randomised to iRehab
12th April: Non-Substantial Amendment 07 implementation date
3rd March: 25 sites open to recruitment
28th Feb: iRehab is now registered with API Scheme
30th Jan: 10 participants randomised to iRehab
2022
13th December 2022: First participant randomised to iRehab
18th November 2022: First 5 sites have received the green light to commence recruitment
18th November 2022: iRehab is now open to recruitment
Chief Investigator:
Dr Brenda O'Neill
Co-Chief Investigator:
Prof Danny McAuley
Sponsor:
Funder:
Registration Number:
Enquiries:
Please direct all enquiries to the iRehab team;
Kerry Raynes: Trial Manager
Sarah Lowe, Trial Manager
Katherine Jones, Research Fellow
Email: iRehab@warwick.ac.uk
Tel: 02476151367